Short-term outcomes of the new intragastric balloon End-Ball® for treatment of obesity

Marek Buzga; Tomas Kupka; Milan Siroky; Habib Narwan; Evzen Machytka; Pavol Holeczy; Zdeněk Švagera

doi:10.5114/wiitm.2016.63988

!!!NEW!!! CLINICAL FORUM !!!NEW!!!
to make the quarterly livelier and more beneficial for doctors and scientists !!!

On June the 1st, 2021 VSJ launches a new discussion platform in the journal.

We invite all MIS surgeons to rapidly submit for publication:
- small forms describing unusual clinical situations related to their practice,
- short clinical comments relating to any publications in VSJ, including the clinical situations described above
- brief communications of original studies deserving fast publication
- your personal opinions as part of a larger discussion on the VSJ publication
- letters concerning the topics described above

Clinical Forum gives you a means of rapid presentation of your findings in the medical databases, scientific citations on the international forum, and also an Impact Factor!

For further details, see: Instructions for Authors

eISSN: 2299-0054
ISSN: 1895-4588

Videosurgery and Other Miniinvasive Techniques

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2016
vol. 11

Send email

Copy url:

abstract:

Original paper

Short-term outcomes of the new intragastric balloon End-Ball® for treatment of obesity

Marek Buzga

,

Tomas Kupka

,

Milan Siroky

,

Habib Narwan

,

Evzen Machytka

,

Pavol Holeczy

,

Zdeněk Švagera

Videosurgery Miniinv 2016; 11 (4): 229–235

DOI: https://doi.org/10.5114/wiitm.2016.63988

Online publish date: 2016/11/29

View full text Get citation

PlumX metrics:

Introduction: Intragastric balloons (IGBs) have been successfully used to treat obesity for the last 18 years. These balloons are made of different materials and filled with either air or saline. It seems that balloons filled with saline result in more effective weight loss, but are associated with worse tolerance after implantation. In contrast, balloons filled with air are associated with excellent tolerance, but result in less effective weight loss.

Aim: To report the early safety and effectiveness results of the End-Ball® balloon and to encourage discussions on how to best use this new-generation IGB for endoscopic weight loss management.

Material and methods: Twenty obese patients (mean age: 40.5 years; mean body mass index: 34.8 kg/m2) were included in a 6-month study. Balloons were inflated with 300 ml of saline containing 5 ml of methylene blue and 300 cm3 of air.

Results: No serious adverse events occurred during treatment. Patients experienced varying degrees of nausea, vomiting (mean: 3.7 times the first day), and abdominal pain after implantation. Six months (23–29 weeks) after End-Ball® balloon insertion, we observed a significant decrease in body weight (13.9 ±5.1 kg) and percent excess weight loss (37.9 ±12.9%). We also found a significant decrease in the levels of glycated hemoglobin (p < 0.001), C-peptide (p < 0.002), and triacylglycerols (p < 0.001) and an increase in the concentration of high-density lipoprotein cholesterol (p < 0.025).

Conclusions: The End-Ball® IGB is a safe and effective treatment for morbid obesity, with positive effects on weight loss and saccharide metabolism.

keywords:

Short-term outcomes of the new intragastric balloon End-Ball® for treatment of obesity

Marek Buzga , Tomas Kupka , Milan Siroky , Habib Narwan , Evzen Machytka , Pavol Holeczy , Zdeněk Švagera

intragastric balloon, obesity, weight loss, safety, End-Ball®

Marek Buzga

,

Tomas Kupka

,

Milan Siroky

,

Habib Narwan

,

Evzen Machytka

,

Pavol Holeczy

,

Zdeněk Švagera